1,652
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells

& ORCID Icon
Pages 755-762 | Received 04 Jan 2021, Accepted 01 Feb 2021, Published online: 23 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Xuedong Yin, Qiaoling Yang, Hongjing Li, Yulin Kang & Zhiling Li. (2023) Vancomycin Induced Ferroptosis in Renal Injury Through the Inactivation of Recombinant Glutathione Peroxidase 4 and the Accumulation of Peroxides. Drug Design, Development and Therapy 17, pages 283-295.
Read now
Jia Gu, Sunil Rauniyar, Yan Wang, Wenjian Zhan, Chengkun Ye, Shaogan Ji & Guanzheng Liu. (2021) Chrysophanol Induced Glioma Cells Apoptosis via Activation of Mitochondrial Apoptosis Pathway. Bioengineered 12:1, pages 6855-6868.
Read now
Ying Ding, Jingyu Wang & Jun Lu. (2021) miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1). Bioengineered 12:1, pages 6771-6781.
Read now
Hui Li, Ji Xuan, Wei Zhang, Zhentao An, Xinyu Fan, Min Lu & Yaozhou Tian. (2021) Long non-coding RNA SNHG5 regulates ulcerative colitis via microRNA-375 / Janus kinase-2 axis. Bioengineered 12:1, pages 4150-4158.
Read now

Articles from other publishers (3)

Aarti Sharma, Sonalika Bhalla & Sidharth Mehan. (2022) PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats. Metabolic Brain Disease 37:6, pages 1909-1929.
Crossref
Wenjie Peng, Pei Wu, Minghao Yuan, Bo Yuan, Lian Zhu, Jiesong Zhou & Qian Li. (2022) Potential Molecular Mechanisms of Recurrent and Progressive Meningiomas: A Review of the Latest Literature. Frontiers in Oncology 12.
Crossref
Lixiu Sun, Jiaxin Gai, Shuai Shi, Jia Zhao, Xiaopeng Bai, Bingchen Liu & Xueqi Li. (2021) Protease-Activated Receptor 2 (PAR-2) Antagonist AZ3451 Mitigates Oxidized Low-Density Lipoprotein (Ox-LDL)-Induced Damage and Endothelial Inflammation. Chemical Research in Toxicology 34:10, pages 2202-2208.
Crossref